TGF-β signaling and the fibrotic response
The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor‐β (TGF‐β), connective tissue growth factor (CTGF, CCN2), and ED‐A fibronectin (ED‐A FN) and the antifibrotic proteins tumor necrosis factor‐α (TNF‐α) and γ‐interferon (IFN‐γ).—Leask, A., Abraham, D. J. TGF‐β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-β is the critical mediator of pathological fibrosis after myocardial injury [64].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [64]
In the citing paper
“TNFα also suppresses the TGFβ stimulation of ECM production.62”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [62]
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultRetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“Transcriptional responses induced by IFN- in most cells are mediated through the Jak-Stat pathway (146).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 1×
“IFN- , a pleiotropic cytokine produced by T cells and NK cells, plays fundamental roles in innate and acquired immune responses (145).”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed Central · Cited by 2,203
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 1×
“TSP-1 null mice demonstrate a partial phenotypic overlap with TGF- 1 null animals (30), and integrin 6 / are highly resistant to lung fibrosis induced by the profibrotic drug bleomycin (31).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 5×
“observed in lesions of fibrotic disease (2).”
BackgroundInfluentialMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Research works printed but not linked: 3
- 10.1111/j.1523-1755.2002.kid567.x · doi:10.1111/j.1523-1755.2002.kid567.x · Paper page
- Schmid P., 1998, Enhanced expression oftransforming growth factor-beta type and type II receptors in wound granulation tissue and hyper trophic scar, Am. J. Pathol., 152, 485
- 10.1111/j.1523-1755.1998.00820.x · doi:10.1111/j.1523-1755.1998.00820.x · Paper page
Cited by
Items 901–1,000 of 1,008
Robertson, J. V., Nathu, Z., Najjar, A., Dwivedi, D. J., Gauldie, J., & West‐Mays, J. A. (2007) · PubMed Central · Cited by 41
Zhang, J., An, S. J., Fu, J. Q., Liu, P., Shao, T. M., Li, M., Li, X., Jiao, Z., & Chai, X. Q. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452550 · Cited by 44
Ramasamy, V., Mayosi, B. M., Sturrock, E. D., & Ntsekhe, M. (2018) · World Journal of Cardiology · doi:10.4330/wjc.v10.i9.87 · Cited by 43
Lagares, D., Busnadiego, O., García-Fernández, R. A., Lamas, S., & Rodríguez-Pascual, F. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0446oc · Cited by 40
Gualou Xiebai Decoction prevents myocardial fibrosis by blocking TGF-beta/Smad signalling
Ding, Y., Peng, Y., Li, J., Shen, H., Ming-qin, S., & Tai-hui, F. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12102 · Cited by 40
“Even at low concentrations, TGF-b could enhance ECM proteins such as collagens and fibronectin synthesis via inducing Smad activation.([11,12]) Currently, drugs acted on TGF-b, endothelin-1 (ET-1), and angiotensin II (Ang II) are being under consideration as antifibrotic therapies.”
BackgroundShirasaki, T., Honda, M., Shimakami, T., Murai, K., Shiomoto, T., Okada, H., Takabatake, R., Tokumaru, A., Sakai, Y., Yamashita, T., et al. (2014) · Hepatology · doi:10.1002/hep.27277 · Cited by 40
Grundtman, C., Jakic, B., Buszko, M., Onestingel, E., Almanzar, G., Demetz, E., Dietrich, H., Cappellano, G., & Wick, G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.044 · Cited by 40
“It has been shown that TGF-b1 promotes fibrosis [24,25] i.”
BackgroundRole of viral infections in the etiopathogenesis of systemic sclerosis.
Moroncini, G., Mori, S., Tonnini, C., & Gabrielli, A. (2013) · PubMed · Cited by 48
Stegemann, A., Sindrilaru, A., Eckes, B., del Rey, A., Heinick, A., Schulte, J. S., Müller, F. U., Grando, S. A., Fiebich, B. L., Scharffetter‐Kochanek, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37809 · Cited by 44
Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity?
Pozdzik, A. A., Berton, A., Schmeiser, H. H., Missoum, R. W., Decaestecker, C., Salmon, I. J., Vanherweghem, J., & Nortier, J. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03509.x · Cited by 40
Biological effects of direct and indirect manipulation of the fascial system. Narrative review
Parravicini, G., & Bergna, A. (2017) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2017.01.005 · Cited by 40
Innate Immune Cytokines, Fibroblast Phenotypes, and Regulation of Extracellular Matrix in Lung
Richards, C. D. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0112 · Cited by 42
“Clearly, many studies have shown TGF-b as central to fibrotic processes and also a potent factor in generation of the myofibroblast phenotype (Leask and Abraham 2004; Kendall and Feghali-Bostwick 2014; Wynn and Vannella 2016).”
Guan, S., Liu, Q., Han, F., Gu, W., Song, L., Zhang, Y., Guo, X., & Xu, W. (2017) · BioMed Research International · doi:10.1155/2017/6510198 · Cited by 41
Dunham, C. L., Havlioglu, N., Chamberlain, A. M., Lake, S. P., & Meyer, G. A. (2020) · The FASEB Journal · doi:10.1096/fj.202001274r · Cited by 42
Zhu, W., Ding, Q., Wang, L., Xu, G., Diao, Y., Qu, S., Chen, S., & Shi, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108212 · Cited by 43
Intracellular Signaling of Cardiac Fibroblasts
Roche, P. L., Filomeno, K. L., Bagchi, R. A., & Czubryt, M. P. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140044 · Cited by 45
Gao, J., Huang, Y., Li, P., Xu, D., Li, J., Liu, Y., Huang, Z., Wu, Q., & Shao, X. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.03.013 · Cited by 40
Receptor-activated Smad localisation in Bleomycin-induced pulmonary fibrosis
Higashiyama, H., Yoshimoto, D., Okamoto, Y., Kikkawa, H., Asano, S., & Kinoshita, M. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.037606 · Cited by 40
Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation
Lavoz, C., Rodrigues‐Díez, R., Benito‐Martín, A., Rayego‐Mateos, S., Rodrigues-Díez, R. R., Alique, M., Ortíz, A., Mezzano, S. A., Egido, J., & Ruiz‐Ortega, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040490 · Cited by 43
“TGF-b1 is a key profibrotic cytokine that contributes to tubulointerstitial damage and renal fibrosis [22–24].”
BackgroundLi, J., Philip, J. L., Xu, X., Theccanat, T., Razzaque, A. M., & Akhter, S. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.08.006 · Cited by 40
“Previous work has demonstrated that transforming growth factor-β (TGF-β) and angiotensin II are the major agonists that stimulate CF transformation and fibrosis in the heart and other organs [6,7].”
BackgroundKopp, M. A., Brommer, B., Gatzemeier, N., Schwab, J. M., & Prüß, H. (2010) · Glia · doi:10.1002/glia.21045 · Cited by 47
“It participates in fibrosis and tissue remodeling, mainly through downstream mediators including Sema7A (Kang et al., 2007; Leask and Abraham, 2004).”
BackgroundSemaphorin 7A Contributes to West Nile Virus Pathogenesis through TGF-β1/Smad6 Signaling
Sultana, H., Neelakanta, G., Foellmer, H. G., Montgomery, R. R., Anderson, J. F., Koski, R. A., Medzhitov, R. M., & Fikrig, E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201140 · Cited by 44
Wang, H., Zhang, H., Zhang, Y., Wang, D., Cheng, X., Yang, F., Zhang, Q., Xue, Z., Li, Y., Zhang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12655 · Cited by 40
Wang, Y., Wang, H., Zhou, R., Zhong, W., Lu, S., Ma, Z., & Chai, Y. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000495 · Cited by 40
Russo, R. C., Savino, B., Mirolo, M., Buracchi, C., Germano, G., Anselmo, A., Zammataro, L. A., Pasqualini, F., Mantovani, A., Locati, M., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00233.2017 · Cited by 43
EDA Fibronectin in Keloids Create a Vicious Cycle of Fibrotic Tumor Formation
Kelsh, R., McKeown‐Longo, P. J., & Clark, R. A. F. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.155 · Cited by 40
“Over two decades ago, transforming growth factor-β (TGF-β) was first identified as a modulator of the EDA isoform levels in fibroblasts, resulting in an increased ratio of EDA to total FN (Balza et al., 1988; Borsi et al., 1990; reviewed in Leask and Abraham (2004)).”
BackgroundDierksheide, J. E., Baiocchi, R. A., Ferketich, A. K., Roychowdhury, S., Pelletier, R. P., Eisenbeis, C. F., Caligiuri, M. A., & VanBuskirk, A. M. (2004) · Blood · doi:10.1182/blood-2003-07-2476 · Cited by 40
Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis
Roach, K., Castells, E., Dixon, K., Mason, S., Elliott, G., Marshall, H., Poblocka, M., Macip, S., Richardson, M., Khalfaoui, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.679388 · Cited by 39
Zhao, M., Wang, M., Chen, X., Gao, Y., Chen, Q., Wang, L., Bao, Q., Sun, D., Du, W., Xu, Y., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133199 · Cited by 40
Shen, Z.-J., Hu, J., Esnault, S. J., Dozmorov, I. M., & Malter, J. S. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.012 · Cited by 40
Luo, X., Pan, Q., Liu, L., & Chegini, N. (2007) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-5-35 · Cited by 39
Zhang, T., Chen, H., Wang, L., Bai, M.-H., Wang, Y., Jiang, X., & Liu, M. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.1.273 · Cited by 39
“Previous studies have suggested that SMAD mutation and dysfunction plays an important role in the development of tumors (Tian et al., 2003; Leaslc and Abraham, 2004; Xu and Pasche, 2007; Su et al., 2010).”
BackgroundWang, L.-X., Yang, X., Yuan, Y., Fan, T., Hou, J., Chen, G., Liang, M., & Wu, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178619 · Cited by 40
Keenan, C. R., Langenbach, S. Y., Jativa, F., Harris, T., Li, M., Chen, Q., Xia, Y., Gao, X., Schuliga, M. J., Jaffar, J., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00738 · Cited by 43
“To confirm a functional effect of PF670462 in preventing TGF-β induced EMT, E-cadherin was immunostained.”
BackgroundInfluentialMolecular Mechanisms and Potential Therapeutic Targets in Incisional Hernia
Thankam, F. G., Gunasekar, P., Fitzgibbons, R. J., & Agrawal, D. K. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.11.037 · Cited by 39
Hseu, Y., Yang, T., Li, M., Rajendran, P., Mathew, D. C., Tsai, C.-H., Lin, R., Lee, C.-C., & Yang, H. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13973 · Cited by 43
Hu, B., Mao, Z., Du, Q., Jiang, X., Wang, Z., Xiao, Z., Zhu, D., Wang, X., Zhu, Y., & Wang, H. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.03.013 · Cited by 41
Lee, H. Y., Nam, S., Kim, M. J., Kim, S. J., Back, S. H., & Yoo, H. J. (2021) · Metabolites · doi:10.3390/metabo11050258 · Cited by 40
Shu, J., Hu, L., Wu, Y., Chen, L., Huang, K., Wang, Z., & Liang, M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174805 · Cited by 42
A conserved TGFβ1/HuR feedback circuit regulates the fibrogenic response in fibroblasts
Bai, D., Gao, Q., Li, C., Ge, L., Gao, Y. J., & Wang, H. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.003 · Cited by 41
Lu, D., & Insel, P. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.466102 · Cited by 42
“TGF- receptor/Smad signaling in fibroblasts is strongly pro-fibrotic and induces the synthesis of ECM and expression of -SMA (13, 14).”
BackgroundTransforming Growth Factor-β and Angiotensin in Fibrosis and Burn Injuries
Gabriel, V. (2009) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181a28ddb · Cited by 42
“cleavage and activation may occur because of interactions with matrix metalloproteinases, acidic environments, and integrins.(4,7,8) As illustrated in Figure 1A, B, TGF- is believed to have two major transmembrane receptors.”
BackgroundRosenzweig, D. H., Ou, S. J., & Quinn, T. M. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12034 · Cited by 41
Xu, Y., Tabe, Y., Jin, L., Watt, J. C., McQueen, T. J., Ohsaka, A., Andreeff, M., & Konopleva, M. Y. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07130.x · Cited by 42
“The TGF-b-Smad pathway is known to promote the production of ECM components, including fibronectin (Moustakas et al, 2001; Leask & Abraham, 2004), and to stimulate the expression of integrin tumour receptors (Letterio & Roberts, 1998; Blobe et al, 2000).”
BackgroundIncreased expression of p21WAF1/CIP1 in kidney proximal tubules mediates fibrosis
Megyesi, J. K., Tarcsafalvi, A., Li, S., Hodeify, R. F., Seng, N. S. H. L., Portilla, D., & Price, P. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00489.2014 · Cited by 42
IGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response
Sureshbabu, A., Okajima, H., Yamanaka, D., Shastri, S., Tonner, E., Rae, C. J., Szymanowska, M., Shand, J. H., Takahashi, S., Beattie, J., et al. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370882 · Cited by 39
Tsai, M.-T., Chen, C., Pan, Y., Wang, S.-H., Mersmann, H. J., & Ding, S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/725379 · Cited by 42
“…progress, whereas IL-6 represents the inflammation in respond to CCl 4 stimulation in liver [36]; TGF-𝛽1 as a key cytokine is involved in the pathogenesis of fibrosis in liver and the initiator of activated HSCs [16]; ACTA2 also known as alpha smooth muscle actin (𝛼-SMA) is a marker of…”
BackgroundZhang, Y., Liu, Z., Wang, K., Lu, S., Fan, S., Xu, L., & Cai, B. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57025 · Cited by 40
Choi, Y. J., Kim, D. H., Kim, S. J., Kim, J., Jeong, S.-I., Chung, C. H., Yu, K.-Y., & Kim, S. Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.05.012 · Cited by 41
Ruiz, X. D., Mlakar, L. R., Yamaguchi, Y., Su, Y., Larregina, A. T., Pilewski, J. M., & Feghali-Bostwick, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043049 · Cited by 39
ERK5 Inhibition Ameliorates Pulmonary Fibrosis via Regulating Smad3 Acetylation
Kim, S., Lim, J. H., & Woo, C.-H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.014 · Cited by 41
Paloschi, V., Gådin, J. R., Khan, S. A., Björck, H. M., Du, L., Maleki, S., Roy, J., Lindeman, J. H. N., Mohamed, S. A., Tsuda, T., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304996 · Cited by 40
Kim, H.-Y., Sah, S. K., Choi, S. S., & Kim, T. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.056 · Cited by 42
Hammoud, L., Lu, X., Lei, M., & Feng, Q. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-010-0147-7 · Cited by 38
“As EGF inhibits collagen synthesis [22, 23] and regulates the expression of TGF-b 1[ 44], a critical inducer for collagen production [3, 24, 25 ] and since we have recently demonstrated that TIMP-3 inhibits EGF signaling in the heart [17], we measured EGF and TGF-b1 levels in both WT and TIMP-3 -/- mice following MI.…”
BackgroundBesschetnova, T. Y., Ichimura, T., Katebi, N., Croix, B. S., Bonventre, J. V., & Olsen, B. R. (2015) · Matrix Biology · doi:10.1016/j.matbio.2014.12.002 · Cited by 42
“In turn, this is likely contributing to increased levels of TGF-β1 and CTGF, with the latter being a direct target of Hif-1α as well as a downstream effector of TGF-β1 profibrotic activity [36,37].”
BackgroundThe role of cold shock domain proteins in inflammatory diseases
Lindquist, J. A., Brandt, S., Bernhardt, A., Zhu, C., & Mertens, P. R. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1136-3 · Cited by 39
Chang, M.-H., Kuo, W., Chen, R., Lu, M.-C., Tsai, F., Kuo, W., Chen, L.-Y., Wu, W.-J., Huang, C., & Chu, C. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0051 · Cited by 44
“TGF-b, a powerful inducer of matrix gene expression in many cell types, plays an integral role in fibrogenesis (Leask & Abraham 2004), indicating that IGF2R may play an important role in myocardial remodeling fibrinolysis.”
BackgroundRegulation of fibronectin gene expression in cardiac fibroblasts by scleraxis
Bagchi, R. A., Lin, J. J., Wang, R., & Czubryt, M. P. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2439-1 · Cited by 38
“…tissues, and we have similarly shown that TGFβ regulates scleraxis expression via both canonical Smad-dependent and non-canonical Smad-independent pathways (Bagchi and Czubryt 2012; Hocevar et al. 1999; Ignotz and Massague 1986; Leask and Abraham 2004; Roberts et al. 1988; Zeglinski et al. 2016).”
BackgroundRasooli, R., Pourgholamhossein, F., Kamali, Y., Nabipour, F., & Mandegary, A. (2017) · Inflammation · doi:10.1007/s10753-017-0671-9 · Cited by 38
Burke, K. E., Ananthakrishnan, A. N., Lochhead, P. J., Olén, O., Ludvigsson, J. F., Richter, J. M., Chan, A. T., & Khalili, H. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy005 · Cited by 39
Distinctive Molecular Composition of Human Gingival Interdental Papilla
Csiszar, A., Wiebe, C., Larjava, H., & Häkkinen, L. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060165 · Cited by 39
Liu, X., Kelm, R. J., & Strauch, A. R. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-0994 · Cited by 37
Biomarkers for skin involvement and fibrotic activity in scleroderma
Moinzadeh, P., Denton, C. P., Abraham, D., Ong, V. H., Hunzelmann, N., Eckes, B., & Krieg, T. M. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04206.x · Cited by 40
Self-citationMathison, M. N., Singh, V., Sanagasetti, D., Yang, L., Pinnamaneni, J. P., Yang, J., & Rosengart, T. K. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.06.035 · Cited by 38
“Consistent with these observations, we have also noted that GMT administration significantly reduced the ventricular infarct population of myofibroblasts (MFs), which are thought to be differentiated from quiescent cardiac fibroblasts by inflammatory stimuli such as transforming growth factor-b and responsible for ind…”
Medeiros, N. I., de Mattos, R. T., Menezes, C. A., Fares‐Gusmao, R., Talvani, A., Dutra, W. O., Rios-Santos, F., Corrêa‐Oliveira, R., & Gomes, J. D. A. S. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1515-y · Cited by 41
Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients
Balázs, K., Antal, L., Sáfrány, G., & Lumniczky, K. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040296 · Cited by 41
Type I collagen structure, synthesis, and regulation
Bou–Gharios, G., Abraham, D., & Crombrugghe, B. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00013-0 · Cited by 49
Self-citationApplication of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Saleh, M., Kiaei, S. Z. F., & Kavianpour, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02746-x · Cited by 39
“In the adult lung, TGF-β-mediated overexpression of Smad3 plays a vital role in the development of extensive fibrosis [92].”
BackgroundUchinaka, A., Hamada, Y., Mori, S., Miyagawa, S., Saito, A., Sawa, Y., Matsuura∥, N., Yamamoto, H., & Kawaguchi, N. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2495-y · Cited by 41
Bevacizumab modulates the process of fibrosis in vitro
Zhang, M., Chu, S.-J., Zeng, F., & Xu, H. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12374 · Cited by 39
Yoshimoto, T., Fujita, T., Kajiya, M., Matsuda, S., Ouhara, K., Shiba, H., & Kurihara, H. (2015) · Cytokine · doi:10.1016/j.cyto.2015.03.011 · Cited by 37
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
Rani, B., Cao, Y., Malfettone, A., Tomuleasa, C., Fabregat, I., & Giannelli, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i15.4128 · Cited by 40
Reduction of isoprenaline-induced myocardial TGF-β1 expression and fibrosis in osthole-treated mice
Chen, R., Xue, J., & Xie, M.-L. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.08.005 · Cited by 37
Transactivation of the Epidermal Growth Factor Receptor by Angiotensin II in Glomerular Podocytes
Flannery, P. J., & Spurney, R. F. (2006) · Nephron Experimental Nephrology · doi:10.1159/000092196 · Cited by 37
Ohno, T., Hirano, S., & Rousseau, B. (2009) · The Laryngoscope · doi:10.1002/lary.20174 · Cited by 37
Activin A in Carcinoid Heart Disease: A Possible Role in Diagnosis and Pathogenesis
Bergestuen, D. S., Edvardsen, T., Aakhus, S., Ueland, T., Øie, E., Vatn, M., Aukrust, P., & Thiis‐Evensen, E. (2010) · Neuroendocrinology · doi:10.1159/000318014 · Cited by 37
Fineschi, S., Cozzi, F., Burger, D., Dayer, J. M., Meroni, P. L., & Chizzolini, C. (2007) · Rheumatology · doi:10.1093/rheumatology/kem241 · Cited by 37
Circulating fibrocytes and Crohn's disease
Sahebally, S. M., Burke, J. P., Chang, K. H., Kiernan, M. G., O’Connell, P. R., & Coffey, J. C. (2013) · British journal of surgery · doi:10.1002/bjs.9302 · Cited by 41
Dong, F., Liu, T., Jin, H., & Wang, W. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0522 · Cited by 37
Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts
Koo, J. B., Nam, M.-O., Jung, Y., Yoo, J., Kim, D. H., Kim, G., Shin, S. J., Lee, K. M., Hahm, K. B., Kim, J. W., et al. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0627-4 · Cited by 40
Kanangat, S., Postlethwaite, A. E., Higgins, G. C., & Hasty, K. A. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700097 · Cited by 36
Guimarães, D. A., Rizzi, É., Ceron, C. S., Martins-Oliveira, A., Gerlach, R. F., Shiva, S., & Tanus-Santos, J. E. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.017 · Cited by 41
Biosimulation of Inflammation and Healing in Surgically Injured Vocal Folds
Li‐Jessen, N. Y. K., Vodovotz, Y., Hebda, P. A., & Abbott, K. V. (2010) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348941011900609 · Cited by 39
Phillips, A. A., Matin, N., Frias, B., Zheng, M., Jia, M., West, C. R., Dorrance, A. M., Laher, I., & Krassioukov, A. V. (2015) · The Journal of Physiology · doi:10.1113/jp270925 · Cited by 37
“These factors have each been shown to induce profibrosis (Leask & Abraham, 2004; Duprez, 2006; Marchesi et al. 2008; Tuday et al. 2009; Sofronova et al. 2015).”
BackgroundProtective effects of alpha lipoic acid on radiation-induced salivary gland injury in rats
Kim, J. H., Kim, K. M., Jung, M. H., Jung, J. H., Kang, K. M., Jeong, B. K., Kim, J. P., Park, J. J., & Woo, S. H. (2016) · Oncotarget · doi:10.18632/oncotarget.8661 · Cited by 36
Ding, Q., Sun, J., Xie, W., Zhang, M., Zhang, C., & Xu, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.030 · Cited by 36
Cadherin-11 Is a Regulator of Intestinal Fibrosis
Franzè, E., Monteleone, I., Laudisi, F., Rizzo, A., Dinallo, V., Fusco, D. D., Colantoni, A., Ortenzi, A., Giuffrida, P., Carlo, S. D., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz147 · Cited by 37
Nanoparticle conjugation of ginsenoside Rb3 inhibits myocardial fibrosis by regulating PPARα pathway
Zhang, Y., Ji, H., Qiao, O., Li, Z., Pecoraro, L., Zhang, X., Han, X., Wang, W., Zhang, X., Man, S., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111630 · Cited by 42
Bengel, F. M., Diekmann, J., Hess, A., & Jerosch‐Herold, M. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264867 · Cited by 37
Hypertrophic Scars and Keloids in Surgery
Song, C. (2014) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000000256 · Cited by 36
Wang, C., Xuan, X.-P., Yao, W., Huang, G., & Jin, J. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3500 · Cited by 39
25-Hydroxycholesterol promotes fibroblast-mediated tissue remodeling through NF-κB dependent pathway
Ichikawa, T., Sugiura, H., Koarai, A., Kikuchi, T., Hiramatsu, M., Kawabata, H., Akamatsu, K., Hirano, T., Nakanishi, M., Matsunaga, K., et al. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.014 · Cited by 41
“In fibroblasts, TGF-b1 upregulates a-SMA and F-actin expression [24], and ECM protein production including collagen I, fibronectin, and tenascin are enhanced [23].”
BackgroundElliott, C. G., & Hamilton, D. W. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0131-5 · Cited by 40
“TGFβ signaling has been extensively reviewed elsewhere (Leask and Abraham 2004; Varga and Abraham 2007).”
BackgroundInfluentialZhang, P., Wang, W., Wang, X., Wang, X., Song, Y., Zhang, J., & Zhao, H. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.113 · Cited by 38
“TGFβ1 is the best positive regulator of myofibroblast differentiation in many fibrotic processes [7,20].”
BackgroundJoseph, J., Mohanty, M., & Mohanan, P. V. (2010) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-4015-7 · Cited by 36
“It was reported that fibroblasts can transform into myofibroblasts through a process regulated by cytokines such as TGFb, extra cellular matrix molecules such as cellular fibronectin splice variant extra type III domain-A(ED-A) and a mechanically stressed environment [31].”
BackgroundWang, H., Leinwand, L. A., & Anseth, K. S. (2014) · The FASEB Journal · doi:10.1096/fj.14-254623 · Cited by 36
“one of the most prevalent cytokines in fibrotic loci (37),”
BackgroundDroppelmann, C. A., Gutiérrez, J., Vial, C., & Brandan, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807352200 · Cited by 38
Lin, A., Hokugo, A., Choi, J., & Nishimura, I. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090256 · Cited by 36
Temporal evolution of gene expression in rat carotid artery following balloon angioplasty
Li, J., Zhang, X., Nelson, P. R., Odgren, P. R., Nelson, J. D., Vasiliu, C., Park, J., Morris, M. E., Lian, J. B., Cutler, B. S., et al. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21190 · Cited by 36
Köppel, H., Riedl, E., Braunagel, M., Sauerhoefer, S., Ehnert, S., Godoy, P., Sternik, P., Dooley, S., & Yard, B. A. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr324 · Cited by 37
Metadata
- Authors
- Leask, A., & Abraham, D. J.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 816-827
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2122808924
- Cited by
- 2,319
- References
- 153
- Citations by year
- 2026: 53 · 2025: 53 · 2024: 63 · 2023: 79 · 2022: 75 · 2021: 103 · 2020: 99 · 2019: 113 · 2018: 145 · 2017: 174 · 2016: 163 · 2015: 179 · 2014: 141 · 2013: 134 · 2012: 115
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Scleroderma Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TGF-beta signaling, fibrosis, fibrogenesis, extracellular matrix deposition, connective tissue growth factor, ED-A fibronectin, TNF-α, interferon-gamma
- MeSH terms
- Animals, DNA-Binding Proteins, Fibronectins, Fibrosis, Gene Expression Regulation, Humans, Interferon-gamma, Tumor Necrosis Factor-alpha, Wound Healing, Signal Transduction, Trans-Activators, Transforming Growth Factor beta, Extracellular Matrix Proteins, Immediate-Early Proteins, Receptors, Transforming Growth Factor beta, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, Smad3 Protein, Smad4 Protein, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.